EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance

Roberto Coppo iD, Masahiro Inoue

Cells · 2025

DOI: 10.3390/cells14181464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Roberto Coppo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan. Hauptthemen laut MEDLINE: Organoids, Neoplasms, Drug Resistance, Neoplasm, Neoplastic Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cell plasticity, defined as the ability of tumor cells to reversibly adopt distinct functional states, plays a central role in tumor heterogeneity, therapy resistance, and disease relapse. This process enables cells to enter stem-like, dormant, or drug-tolerant persister states in response to treatment or environmental stress without undergoing genetic changes. Such reversible transitions complicate and limit current treatments. Conventional cancer models often fail to capture the complexities of these adaptive states. In contrast, patient-derived tumor organoids (PDOs), which retain the cellular diversity and structure of primary tumors, provide a unique system for investigating plasticity. This review describes how PDOs can model cellular plasticity, such as the emergence of drug-tolerant persister cells and the interconversion between cancer stem cell states across multiple tumor types. We particularly focused on colorectal cancer organoids, for which research on the mechanism of plasticity is the most advanced. Combined with single-cell analysis, lineage tracing, and functional assays, PDOs can help identify the molecular pathways that control plasticity. Understanding these mechanisms is important for developing therapies to prevent treatment failure and control disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsNeoplasmsDrug Resistance, NeoplasmNeoplastic Stem CellsCell Culture Techniques, Three DimensionalCell PlasticityHumansSingle-Cell AnalysisCell Transdifferentiation

Stichwörter der Autor:innen

cancer stem cellscellular plasticitydrug-tolerant persister cellspatient-derived tumor organoidstherapy resistancetumor heterogeneity

Autor:innen und Institutionen

  • Department of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.

ORCID-Profile: Roberto Coppo

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Coppo, R., & Inoue, M. (2025). Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. Cells. https://doi.org/10.3390/cells14181464

Vancouver

Coppo R, Inoue M. Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. Cells. 2025. doi:10.3390/cells14181464

BibTeX
@article{Coppo2025,
  author = {Coppo, Roberto and Inoue, Masahiro},
  title = {Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14181464}
}
Kostenlos starten →